CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (36,546,000)	$ (52,520,000)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Stock-based compensation	30,150,000	21,411,000
Depreciation and amortization	11,451,000	11,867,000
Goodwill impairment	14,916,000	0
Provision for (recovery from) doubtful accounts, net	2,000	(20,000)
Benefit from deferred income taxes	(760,000)	0
Loss (gain) on disposal of fixed assets	15,000	(9,000)
Unrealized gain on fair value adjustment of investment	(750,000)	0
Amortization of debt issuance costs	70,000	70,000
Provision for inventory obsolescence	418,000	108,000
Impairment loss on intangible assets	0	11,706,000
Changes in other operating assets and liabilities:
Accounts receivable	2,170,000	11,272,000
Prepaid expenses, deferred program expenses, other current assets and other assets	(472,000)	(11,926,000)
Accounts payable	2,724,000	(7,121,000)
Accrued compensation and benefits	650,000	(7,395,000)
Contract liabilities	5,510,000	110,000
Accrued liabilities and other liabilities	634,000	(3,491,000)
Net cash provided by (used in) operating activities	30,182,000	(25,938,000)
Cash flows from investing activities:
Capitalized software development costs	(8,176,000)	(11,505,000)
Purchases of property and equipment, net	(739,000)	(2,252,000)
Purchase of investment	0	(3,000,000)
Net cash used in investing activities	(8,915,000)	(16,757,000)
Cash flows from financing activities:
Payments under finance lease obligations	(1,877,000)	(1,730,000)
Payment of tax withholding related to net share settlement of equity awards	(7,254,000)	(457,000)
Proceeds from exercise of stock options	108,000	203,000
Repurchase of common stock	(13,627,000)	0
Payments for debt issuance costs	(14,000)	0
Net cash used in financing activities	(22,664,000)	(1,984,000)
Net change in cash, cash equivalents, and restricted cash	(1,397,000)	(44,679,000)
Cash, cash equivalents and restricted cash, beginning of period	54,717,000	99,396,000
Cash, cash equivalents and restricted cash, end of period	$ 53,320,000	$ 54,717,000